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Background: Descemet’s stripping automated endothelial keratoplasty (DSAEK) has been 
shown to have superior refractive and visual results compared with penetrating keratoplasty, but 
higher rates of primary graft failure (PGF). This paper presents donor and surgical risk factors 
for PGF in DSAEK cases in Asian eyes.
Design: Retrospective case-control study.
Participants: All consecutive patients who underwent DSAEK at a tertiary referral teaching 
hospital from March 2006–December 2008.
Methods: Donor details analyzed were: age of donor, cause of donor death, death to harvesting 
time, donor storage time, distribution distance of tissue, preoperative endothelial cell count. 
Surgical factors analyzed were: donor diameter, donor thickness, and method of donor   insertion. 
These risk factors in cases of PGF were compared with patients with successful DSAEK as 
the control group.
Main outcome measure: PGF.
Results: A total of 124 DSAEK procedures were performed. Six DSAEK procedures (five eyes 
of five patients; one eye with two failures) resulted in PGF (4.8%). Significant risk factors were 
found for PGF to include graft insertion using a folding technique (odds ratio [OR], 34.03; 95% 
confidence interval [CI], 3.75–314.32; P = 0.0017) and a small donor diameter (OR, 39.94; 
95% CI, 2.18–732.17; P = 0.013).
Conclusion: The results of this study suggest that in Asian eyes with shallow anterior chambers, 
surgical trauma relating to the technique of donor insertion, and the use of a small donor are 
major risk factors for PGF following DSAEK.
Keywords: DSAEK, PGF, penetrating keratoplasty
Introduction
Primary graft failure (PGF) refers to failure of the graft to clear after surgery, with 
persistent graft edema relating to endothelial damage or dysfunction.1 There are no 
clearly defined risk factors in the majority of cases, but postulated etiologies which 
have been associated with PGF in penetrating keratoplasty (PK) include donor factors 
such as trauma as a cause of donor death, donor age . 70 years, prolonged death 
to preservation time or prolonged donor storage time,2 endothelial damage during 
donor retrieval or storage,3 and surgical factors relating to surgical technique and 
surgical trauma.4
Descemet’s stripping automated endothelial keratoplasty (DSAEK) is a recent form 
of endothelial keratoplasty procedure in which Descemet’s membrane and diseased 





DSAEK is rapidly increasing in popularity as an alternative to 
conventional PK due to inherent advantages of small   incision, 
closed-globe, sutureless surgery, resulting in enhanced 
structural integrity and more rapid visual recovery relating 
to minimal refractive change and the lack of graft sutures.5 
However, folding and grasping of the donor tissue with for-
ceps to enable insertion through a small incision, intraocular 
manipulation to unfold the donor, the use of intraocular air to 
enable adhesion of the donor to the posterior stromal surface, 
and a significant learning curve, all potentially increase the 
risk of endothelial damage. Recent reports have suggested 
that increased donor endothelial cell loss occurs during auto-
mated donor lamellar dissection and donor unfolding in the 
anterior chamber.6 While PGF following PK is uncommon 
(reported incidence = 2.1%),1 it is the third most common 
reported complication following DSAEK (mean rate = 5.0%; 
range 0%–29%).7 This is further supported by recent reports 
of higher endothelial cell loss at 6 months and 1 year after 
DSAEK, as compared with PK, which is related to more 
donor tissue manipulation in DSAEK.8,9
The authors of this present paper initiated a DSAEK sur-
gical program at the Singapore National Eye Centre (SNEC), 
and graft failures occurring early in the series prompted the 
modification of the folding procedure of donor insertion to a 
pull-through glide technique.10 This suited the smaller Asian 
eye with shallower anterior chamber11 and higher vitreous 
pressure, which creates difficulties particularly with the 
unfolding of the donor in the anterior chamber.
A review of current literature revealed that while many 
papers have described PGF rates and postulated possible 
  etiologies, none have formally assessed clinical or   surgical 
risk factors. Likewise, the majority of reported series of 
DSAEK have been performed in Caucasian eyes with 
  biometrically deeper anterior chambers than Asian (Chinese) 
eyes.11 The authors of this paper thus performed a retrospec-
tive case-control study to determine the donor and surgical 
risks for PGF in DSAEK for Asian eyes.
Methods
A retrospective case-control study was conducted of all 
consecutive patients who underwent DSAEK at SNEC 
from March 2006 to December 2008. These patients were 
identified from the SNEC prospective cornea transplanta-
tion database. All consecutive patients who had undergone 
DSAEK procedures during the study period, which were 
performed by the same surgeon (DT) using previously 
described “taco” folding or glide techniques using a modified 
Sheets glide (BD Visitec™, Beaver-Visitec International, 
Waltham, MA) (see Figure 1) were included.12 The notes for 
information pertaining to indications for DSAEK surgery, 
patient demographics, and surgical details were reviewed. 
Donor details were obtained from the Singapore Eye Bank 
database, including information such as the age of the donor, 
cause of donor death, death to corneal harvesting time, 
donor storage time (procurement to transplantation), and 
  distribution distance of tissue (donors were obtained either 
locally, or from international eye banks based in the USA).1 
Donor and surgical risk factors with patients in the database 
that had undergone successful DSAEK were compared 
as the control group. Successful DSAEK was defined as 
clarity and thinning of the posterior lamellar graft with no 
residual corneal edema within 6 weeks following DSAEK; 
and grafts that had not dislocated and showed no increase in 
thickness in donor size on anterior-segment optical coherence 
  tomography (ASOCT).
Statistical  analysis  was  performed,  comparing 
  demographic and other variables separately. Cases of PGF 
were compared with the control corneas that had under-
gone a successful DSAEK procedure. Univariate results 
are presented in odds ratios (ORs) with 95% confidence 
intervals (CIs). All P values obtained were two-tailed, with 
a significance level of P , 0.05. The protocol of the study 
adhered to the provisions of the Declaration of Helsinki and 
was approved by the institutional review board and local 
ethics committee of the Singapore National Eye Centre and 
Singapore Eye Research Institute. PGF was the main out-
come measure. PGF was diagnosed based on the following 
criteria: (1) the presence of diffuse edema of the posterior 
Figure 1 Intraoperative picture of modified Sheets glide (BD Visitec™, Beaver-
Visitec International, Waltham, MA) used in the glide insertion of donors for the 
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lamellar and recipient corneal stroma apparent from the 
first   postoperative day, (2) failure of the edema to clear 
spontaneously by 2 months, and (3) a lack of other peri- or 
postoperative risk factors such as donor dislocation (donor 
attachment was confirmed in all cases by ASOCT (Visante 
OCT, Carl Zeiss Meditec, Inc, Dublin, CA).
Results
A total of 124 DSAEK procedures were performed from 
March 2006 and December 2008. Six DSAEK procedures 
(five eyes of five patients; one eye with two failures) 
resulted in PGF, hence a total of six primary failures out of 
124 DSAEK procedures (4.8%). There were four females 
and one male patient. Preoperative diagnosis prior to 
graft exchange was bullous keratopathy in four patients 
and Fuchs endothelial corneal dystrophy in one patient. 
  Operations were performed on three right eyes, and two 
left eyes. Mean pre-exchange pachymetry (on ASOCT) 
for recipient corneas was 772 (±standard deviation 94) 
microns and 354 ± 111 microns for the donor lamellar. The 
mean time to graft exchange from primary procedure was 
8 ± 1 weeks. The mean logarithm of minimum angle of reso-
lution (logMAR) spectacle corrected visual acuity (SCVA) 
before graft exchange was 1.300 ± 0.002; compared with 
the mean logMAR SCVA of 0.4 ± 0.07 following exchange 
at 3 months post-operatively (P = 0.0002). All of the PGF 
cases had had posterior donor lamellar exchanges by a previ-
ously reported technique.10 One patient had this procedure 
performed twice.
The mean donor age for the cases of PGF was 
50.0 ± 16.3 years compared with the mean age of the suc-
cessful cases of 57.0 ± 13.7 years (P = 0.3). Four of the 
corneas that had PGF were donor mates. All corneas were 
preserved in Optisol GS® (Chiron Intraoptics, Irvine, CA). 
In this series, only one donor was precut from an eye bank 
in the US (which was not a case of PGF). Hence, no attempt 
was made to compare precut versus nonprecut tissue. The 
time from death to tissue recovery ranged from 1.5 hours to 
24.5 hours. However, some of the donors were refrigerated 
prior to tissue recovery. The mean donor refrigeration time 
was 11.3 ± 5.5 hours. If the refrigeration time is subtracted 
from the total cadaver time in those cases, the overall mean 
cadaver time was 3.8 ± 2.6 hours. The mean cadaver time of 
the PGF cases without refrigeration time was 4.6 ± 2.0 hours, 
including the mean refrigeration time of 9.8 ± 3.6 hours. In 
comparison, the mean cadaver time of the successful cases 
without refrigeration time was 3.8 ± 3.6 hours (P = 0.39), with 
the mean refrigeration time 9.9 ± 3.0 hours (P = 0.5).
The overall mean storage time of the donor tissues was 
5.0 ± 1.8 days (range, 2–7 days). The mean storage time of the 
PGF cases was 5.8 ± 1.4 days compared with the mean stor-
age time of the successful cases of 4.8 ± 1.9 days (P = 0.18). 
There was no significant difference between preoperative 
endothelial cell density (ECD) of the donors used in the suc-
cessful cases and the cases with PGF (2903 ± 235 cells/mm2 
versus 2795 ± 100 cells/mm2, P = 0.06). Correlation analysis 
showed no association between cause of death and the age of 
the donor cornea or between age of donor and ECD; or ECD 
and donor storage time. There was no significant difference 
in the mean corneal donor thickness of the successful cases 
compared with those with PGF (203 ± 51 microns versus 
202 ± 75 microns, P = 0.55).
Table 1 illustrates the selected donor and surgical 
  variables for cases of PGF with those of controls (successful 
DSAEK cases). Significant risk factors were found for PGF to 
include graft insertion using a folding technique (OR, 34.03; 
95% CI, 3.75–314.32; P = 0.0017) and a small donor diameter 
(OR, 39.94; 95% CI, 2.18–732.17; P = 0.013). There was no 
significant difference between the two groups for the other 
risk factors, such as donor cadaver time ($12 hours), stor-
age time ($7 days), source of tissue (local versus foreign), 
preoperative ECD ($2801), donor age ($71) cause of death 
(trauma), and thickness of donor posterior lamella (#250). 
On multivariate analysis, with technique (P = 0.066) and 
donor size (P = 0.997) controlling for each other, neither 
was significant.
Discussion
Endothelial damage with DSAEK surgery remains the major 
challenge to this new procedure, which is rapidly emerging 
as a popular alternative to PK surgery worldwide. When the 
DSAEK program was initiated at SNEC, it was noticed that 
there were not only difficulties with donor insertion but also 
unfolding the donor graft in a shallow anterior chamber, com-
monly seen in Asian Eyes, required increased manipulation 
of donor lenticule.11 This increased the risk of endothelial 
cell damage while performing DSAEK and thus possible 
greater risk of PGF. The mean rate of PGF following DSAEK 
in published literature is 5% (range = 0%–29%),7 which is 
similar to the initial PGF rate (4.8%) in this present series. 
However, the authors of this present paper feel this rate to be 
unacceptably high, hence an attempt to evaluate causation in 
this study at this early stage in the program. All the tissues 
that were used in these present DSAEK cases would have 
been acceptable for standard PK and the rate for PGF in PK 





selection was unlikely to be a factor. The rates for PGF in 
DSAEK are pertinent given the fact that DSAEK surgeons 
today are in fact requesting for, and utilizing, corneas with 
higher endothelial cell counts to perform this procedure.13
No significant effect of selected donor risk factors 
accounting for PGF in the cases of DSAEK in this present 
study was observed. The donor risk factors that were exam-
ined have been previously identified as proposed risk factors 
for PGF.1 These include donor age . 70, trauma as a cause 
of death, a death to preservation time of over 12 hours, and a 
storage time of greater than 7 days.1 Once refrigeration time 
was excluded, none of the donor corneas used in this study 
had a death-to-preservation time of more than 12 hours. This 
study also looked at the effect of refrigeration of the donor 
prior to eye removal but no statistical difference was found 
in cases of PGF and controls whether the refrigeration time 
was included in the cadaver time or not.
Also included were other donor risk factors that may 
be pertinent to SNEC’s local tissue requirement and many 
centers worldwide doing DSAEK that import tissue from 
overseas. Fifty percent of the donor tissue used at SNEC 
  during this study came from the USA. Transportation of 
tissue overseas may have a detrimental effect on the endothe-
lium, especially if there is excessive vibration.14 The results 
of this present study indicated that there were no detrimental 
effects on DSAEK outcomes comparing locally sourced 
and USA-sourced tissue. A trend to request tissue with 
higher endothelial cell count also prompted us to compare 
results of tissue with endothelial cell counts in excess of 
2800 cells/mm2; again there was no significant difference 
between controls and those with PGF. Terry et al also showed 
that there was no significant correlation between preoperative 
donor ECD and rates of dislocation in DSAEK; although 
their results were unable to show its relationship to PGF as 
compared with this present study.15 Due to the donor pres-
ervation methods used at SNEC and also in tissue sent from 
the USA (both Optisol GS), it was not possible to compare 
the effects of tissue storage, ie, organ culture or Optisol GS, 
on the rates of PGF. Likewise, the majority of the tissue was 
cut by microkeratome at the time of surgery (except for one 
case); hence the result of precut and perioperative cut tissue 
could not be compared with the results of PGF.
Despite ensuring similar donor quality in both PK and 
DSAEK, PGF rates relating to endothelial cell loss or damage 
are still higher in DSAEK.8 Price at al recently reported that 
at 1-year post-transplantation, although overall graft success 
was comparable for DSAEK and PK, the endothelial cell 
loss was greater with DSAEK.16 Recent histopathological 
studies have demonstrated endothelial attenuation (100%), 
endothelial atrophy (75%), and mild stromal inflammation 
(68%) secondary to manipulation and surgical trauma in 
cases of PGF in DSAEK.17,18 Furthermore, in-vitro studies 
have shown that during the DSAEK procedure, endothelial 
cell trauma occurs at several stages.6 This study hence 
examined the effects of donor surgical factors, ie, donor 
diameter size, donor thickness, and donor insertion method, 
Table1 Donor and surgical risk factors for primary graft failure
Parameters Category Outcome (%) Odds ratio 95% confidence interval P-value 
(2 sided) Successa Failureb Lower Upper
Donor source Foreign 69 (94.5) 4 (5.5) 1.4 0.25 8.86 0.692
Local 49 (96.1) 2 (3.9) 1  
Cadaver time, hours ,12 63 (91.3) 6 (8.7) 3.26 0.12 88.37 0.483
$12 1 (100) 0 (0) 1
storage time, days #6.9 52 (94.5) 3 (5.5) 0. 23 0.041 1.29 0.095
$7 12 (80) 3 (20) 1
Donor endothelial cell count,  
cells/mm2
#2800 44 (93.6) 3 (6.4) 1.68 0.33 8.70 0.672
$2801 74 (96.1) 3 (3.9) 1
Donor age, years #70 101 (95.3) 5 (4.7) 0.79 0.086 7.23 0.836
$71 16 (94.1) 1 (5.9) 1
Cause of death Trauma  19 (86.4) 3 (13.6) 5.2 0.007 27.80 0.053
Others 99 (97.1) 3 (2.9) 1
insertion technique Fold 15 (75) 5 (25) 34.03 3.75 314.32 0.0017
glide 103 (99) 1 (1) 1
Donor diameter, mm #8 27 (81.8) 6 (17.2) 39.94 2.18 732.17 0.013
$8.1 84 (100) 0 (0) 1
Donor thickness, microns #250 99 (95.2) 5 (4.8) 0.505 0.054 4.76 0.550
$251 10 (90.9) 1 (9.1) 1
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on the rates of PGF. Analysis showed that a smaller donor 
diameter (#8 mm) and the folding technique were associ-
ated with PGF in this present series. The inference from this 
observation is that larger diameter grafts have less chance of 
failure. A graft of 9 mm diameter transfers 26% more surface 
area of endothelial cells than a graft of 8 mm in diameter.13 
If the donor has a higher number of endothelial cells and 
the attrition rate is constant then there should be less chance 
of failure with larger grafts. Others have found that a larger 
incision leads to less donor lenticule manipulation;19 while 
the increased donor lenticule size confers more endothelial 
cell area, thus providing more cells to deturgesce a swollen 
cornea and less manipulation.18 It has also been suggested 
that larger donor lenticules suffer less manipulation due to 
better centration.20
Grafts of 9 mm are often used for DSAEK in results 
reported from the USA.7 However, in this present study, one 
of the problems noticed in the initial cases was that it was 
difficult to implant a donor of larger than 8 mm in diameter, 
since unfolding of the donor was very difficult in Asian 
eyes with shallow anterior chambers. It was often the case 
that the inferior wing of the folded graft would be unable to 
unfold because impediment by the iris would prevent exten-
sion of this part of the donor tissue. Recently, biometric data 
on a large sample of Asian eyes has shown that the mean 
anterior chamber depth is 2.68 ± 0.3 mm.11 If we presume 
that the donor tissue is folded in a standard 60:40 “taco,” for 
a 9 mm graft, the anterior chamber depth would have to be a 
minimum of 3.6 mm to allow unfolding, without obstruction 
from the iris. The method of donor insertion in this study was 
therefore changed to a technique that doesn’t involve folding 
or unfolding of the donor posterior lamellar.10 Analysis of 
donor insertion technique shows there is a significant risk of 
PGF with “taco” insertion compared with glide (OR, 34.03; 
95% CI, 3.75–314.32; P = 0.0017) in Asian eyes. This is 
consistent with previous reports by Suh et al and Gorovoy et al, 
with difficulties in donor unfolding causing traumatic loss 
of endothelial cells.21,22 The present study did have one case 
of PGF following glide insertion. This was in a patient who 
developed a graft detachment in an excessively thick donor 
button (400 microns), following insertion, which was re-
tamponaded with air, but the graft failed to clear.
The limitations of this study are the inability to assess 
the effect of precut donor tissue, and the effects of donor 
dislocation requiring repeat air tamponade on PGF since 
only one precut donor tissue was used and only two disloca-
tions occurred in this series. However, due to the high rate 
of PGF (even if this comes under the caveat of the “learning 
curve”) and the increased use of good quality donor tissue, the 
authors felt it was important to identify any donor or surgical 
risk factors that may affect early graft survival. Whether 
these patients will be at increased risk of graft rejection 
long term, following repeat re-grafting, remains to be seen. 
Several surgeons have used the surgical learning curve as 
an acceptable excuse for the high rates of PGF following 
DSAEK, and often the first 20 cases may be removed before 
reporting results. In this present study, the first 20 “taco” 
insertions were examined and compared with the first 20 
“glide” insertions, which revealed PGF rates of 25% (5/20) 
versus 5% (1/20) respectively. In fact, the center’s overall 
PGF rate to date using the “glide” insertion is currently 
0.45% (1/220) (including the first 20 cases). Although the 
first 20 glide insertions were performed following the first 20 
“taco” insertions, with no other changes in the surgical tech-
nique, the authors of this paper had the same steep learning 
curve in terms of donor insertion, minimizing any bias.
Statistical analysis comparing the outcomes between 
  corneas from the same donor, may provide more robust 
  statistical analysis of the data, as well as correlation in out-
comes in repeat operations on the same eye, but these were 
not possible since almost 50% of the donors came from   a 
foreign source (USA). When contact tracing of the donor 
mates of these corneas was performed, the authors of this 
paper were informed that many of the corneas had been used 
for PK and not DSAEK. Moreover, the small numbers of PGF 
in this present series limit the statistical power of the results, 
with wide CIs, albeit statistically significant.
The herpes virus genus has been implicated in one-third 
of cases as a cause of PGF following PK.23 In this series, 
  polymerase chain reaction was not performed on any of 
the donor tissue, but there was no evidence of lymhocytic 
infiltration on histology, or presence of viral virions in the 
stromal keratocytes on electron microscopy, of the removed 
failed   tissue.12 Four of the corneas in this present study 
with PGF were mated. Mated corneas may be more likely 
to fail as a result of inherent donor endothelial disease 
or postmortem changes that may affect both eyes. Even 
though all of the mated corneas had endothelial cell counts 
greater than 2500 cells/mm2 and two had counts greater than 
2800 cells/mm2, donor mating may still have an effect.
In summary, endothelial keratoplasty is becoming the 
procedure of choice for many surgeons in the management 
of patients with primary (eg, corneal dystrophies) or second-
ary (bullous keratopathy or graft failure) endothelial failure. 
The results of this present study implicate that it is surgical 
trauma relating to the technique of donor insertion and the Clinical Ophthalmology
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use of a small donor, which appear to be major risk factors 
for PGF following DSAEK in Asian eyes. This study also 
supports recent evidence that it may not be justified to request 
for donors with higher ECD, but instead to choose a better 
surgical technique to reduce endothelial damage.8 If we are to 
avoid an abundance of graft failures and subsequent increase 
in demand of good quality donor corneal tissue,24 efforts must 
be made to reduce endothelial cell trauma when performing 
DSAEK, even in the learning curve period.
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The authors have no financial disclosures or conflict of 
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